Vital Bio-Systems Profile
Key Indicators
- Authorised Capital ₹ 2.40 M
as on 29-12-2024
- Paid Up Capital ₹ 2.20 M
as on 29-12-2024
- Company Age 29 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 66.35%
(FY 2022)
- Profit 275.03%
(FY 2022)
- Ebitda -158.88%
(FY 2022)
- Net Worth 0.45%
(FY 2022)
- Total Assets 0.68%
(FY 2022)
About Vital Bio-Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.40 M and a paid-up capital of Rs 2.20 M, as per Ministry of Corporate Affairs (MCA) records.
Shanthakumar Devakaran and Dolly Shanthakumar serve as directors at the Company.
- CIN/LLPIN
U33112TN1995PTC031324
- Company No.
031324
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 1995
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vital Bio-Systems Private Limited offer?
Vital Bio-Systems Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Medical Pumps, Blood Pressure Machine, Infusion Pumps, Digital Blood Pressure Monitor, Syringe Pump, Blood Pressure Machine Parts & Accessories.
Who are the key members and board of directors at Vital Bio-Systems?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shanthakumar Devakaran  | Director | 01-Jan-1999 | Current |
| Dolly Shanthakumar | Director | 08-Aug-2016 | Current |
Financial Performance of Vital Bio-Systems.
Vital Bio-Systems Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 66.35% increase. The company also saw a substantial improvement in profitability, with a 275.03% increase in profit. The company's net worth moved up by a moderate rise of 0.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vital Bio-Systems?
In 2019, Vital Bio-Systems had a promoter holding of 80.18% and a public holding of 19.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kornerstone Devices Private LimitedActive 7 years 10 monthsShanthakumar Devakaran is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vital Bio-Systems?
Unlock and access historical data on people associated with Vital Bio-Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vital Bio-Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vital Bio-Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
